Stay updated on Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial
Sign up to get notified when there's something new on the Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial page.

Latest updates to the Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe old and new screenshots show the same study record content and status sections with no new or removed data, only minor visual/UI updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference11%

- Check45 days agoChange DetectedUpgrade version from v3.0.2 to v3.1.0; no other content changes are specified.SummaryDifference0.3%

- Check60 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. Removed the 'Back to Top' link.SummaryDifference0.6%

- Check67 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.7%

- Check74 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as extensive updates to study status and contact information. Several previous location-related terms have been removed.SummaryDifference28%

Stay in the know with updates to Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Apitegromab Long-Term Safety & Efficacy in SMA Clinical Trial page.